BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27267072)

  • 1. Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detection.
    Stoll D; Danforth J; Zhang K; Beck A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():51-60. PubMed ID: 27267072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs.
    Chapel S; Rouvière F; Sarrut M; Heinisch S
    Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry.
    Sorensen M; Harmes DC; Stoll DR; Staples GO; Fekete S; Guillarme D; Beck A
    MAbs; 2016 Oct; 8(7):1224-1234. PubMed ID: 27362833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
    Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
    MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical techniques for the characterization of Antibody Drug Conjugates: Challenges and prospects.
    Neupane R; Bergquist J
    Eur J Mass Spectrom (Chichester); 2017 Dec; 23(6):417-426. PubMed ID: 29183195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-line characterization of monoclonal antibody variants by liquid chromatography-mass spectrometry operating in a two-dimensional format.
    Alvarez M; Tremintin G; Wang J; Eng M; Kao YH; Jeong J; Ling VT; Borisov OV
    Anal Biochem; 2011 Dec; 419(1):17-25. PubMed ID: 21867674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
    Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
    Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
    Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
    Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Depth Characterization of a Pro-Antibody-Drug Conjugate by LC-MS.
    Liu B; Guo H; Zhang J; Xue J; Yang Y; Qin T; Xu J; Guo Q; Zhang D; Qian W; Li B; Hou S; Dai J; Guo Y; Wang H
    Mol Pharm; 2016 Aug; 13(8):2702-10. PubMed ID: 27377124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
    Friese OV; Smith JN; Brown PW; Rouse JC
    MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
    Yan Y; Xing T; Wang S; Daly TJ; Li N
    J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry.
    D'Atri V; Fekete S; Stoll D; Lauber M; Beck A; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():37-41. PubMed ID: 29477065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Mass Spectrometric Tools for the Bioanalyses of Therapeutic Monoclonal Antibodies and Antibody-Drug Conjugates.
    Todoroki K; Yamada T; Mizuno H; Toyo'oka T
    Anal Sci; 2018; 34(4):397-406. PubMed ID: 29643301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates.
    Li Y; Gu C; Gruenhagen J; Zhang K; Yehl P; Chetwyn NP; Medley CD
    J Chromatogr A; 2015 May; 1393():81-8. PubMed ID: 25818558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive online multicolumn two-dimensional liquid chromatography-diode array detection-mass spectrometry workflow as a framework for chromatographic screening and analysis of new drug substances.
    Pickens CJ; Haidar Ahmad IA; Makarov AA; Bennett R; Mann BF; Regalado EL
    Anal Bioanal Chem; 2020 Apr; 412(11):2655-2663. PubMed ID: 32128644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Comprehensive Online Two-Dimensional Liquid Chromatography/Mass Spectrometry Using Hydrophilic Interaction and Reversed-Phase Separations for Rapid and Deep Profiling of Therapeutic Antibodies.
    Stoll DR; Harmes DC; Staples GO; Potter OG; Dammann CT; Guillarme D; Beck A
    Anal Chem; 2018 May; 90(9):5923-5929. PubMed ID: 29614857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates.
    Bobály B; Fleury-Souverain S; Beck A; Veuthey JL; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2018 Jan; 147():493-505. PubMed ID: 28688616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High resolution two-dimensional liquid chromatography coupled with mass spectrometry for robust and sensitive characterization of therapeutic antibodies at the peptide level.
    Stoll DR; Lhotka HR; Harmes DC; Madigan B; Hsiao JJ; Staples GO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Dec; 1134-1135():121832. PubMed ID: 31790917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-dimensional LC-MS: the next generation characterization of antibody-based therapeutics by unified online bottom-up, middle-up and intact approaches.
    Camperi J; Goyon A; Guillarme D; Zhang K; Stella C
    Analyst; 2021 Feb; 146(3):747-769. PubMed ID: 33410843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2D-LC/MS techniques for the identification of proteins in highly complex mixtures.
    Nägele E; Vollmer M; Hörth P; Vad C
    Expert Rev Proteomics; 2004 Jun; 1(1):37-46. PubMed ID: 15966797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.